Correlation Between Salesforce and Medeon Biodesign

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Medeon Biodesign at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Medeon Biodesign into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Medeon Biodesign, you can compare the effects of market volatilities on Salesforce and Medeon Biodesign and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Medeon Biodesign. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Medeon Biodesign.

Diversification Opportunities for Salesforce and Medeon Biodesign

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Salesforce and Medeon is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Medeon Biodesign in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medeon Biodesign and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Medeon Biodesign. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medeon Biodesign has no effect on the direction of Salesforce i.e., Salesforce and Medeon Biodesign go up and down completely randomly.

Pair Corralation between Salesforce and Medeon Biodesign

Considering the 90-day investment horizon Salesforce is expected to under-perform the Medeon Biodesign. In addition to that, Salesforce is 1.22 times more volatile than Medeon Biodesign. It trades about -0.29 of its total potential returns per unit of risk. Medeon Biodesign is currently generating about -0.29 per unit of volatility. If you would invest  4,000  in Medeon Biodesign on October 21, 2024 and sell it today you would lose (205.00) from holding Medeon Biodesign or give up 5.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy90.48%
ValuesDaily Returns

Salesforce  vs.  Medeon Biodesign

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Medeon Biodesign 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medeon Biodesign has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Salesforce and Medeon Biodesign Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Medeon Biodesign

The main advantage of trading using opposite Salesforce and Medeon Biodesign positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Medeon Biodesign can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medeon Biodesign will offset losses from the drop in Medeon Biodesign's long position.
The idea behind Salesforce and Medeon Biodesign pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data